Literature DB >> 24802402

A dual functional fluorescent probe for glioma imaging mediated by blood-brain barrier penetration and glioma cell targeting.

Hongwei Ma1, Zhiyong Gao2, Panfeng Yu3, Shun Shen4, Yongmei Liu5, Bainan Xu6.   

Abstract

Glioma is a huge threat for human being because it was hard to be completely removed owing to both the infiltrating growth of glioma cells and integrity of blood brain barrier. Thus effectively imaging the glioma cells may pave a way for surgical removing of glioma. In this study, a fluorescent probe, Cy3, was anchored onto the terminal of AS1411, a glioma cell targeting aptamer, and then TGN, a BBB targeting peptide, was conjugated with Cy3-AS1411 through a PEG linker. The production, named AsT, was characterized by gel electrophoresis, (1)H NMR and FTIR. In vitro cellular uptake and glioma spheroid uptake demonstrated the AsT could not only be uptaken by both glioma and endothelial cells, but also penetrate through endothelial cell monolayer and uptake by glioma spheroids. In vivo, AsT could effectively target to glioma with high intensity. In conclusion, AsT could be used as an effective glioma imaging probe.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AS1411 aptamer; Glioma; Non-invasive imaging; TGN peptide

Mesh:

Substances:

Year:  2014        PMID: 24802402     DOI: 10.1016/j.bbrc.2014.04.148

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

Review 2.  Aptamers: versatile molecular recognition probes for cancer detection.

Authors:  Hongguang Sun; Weihong Tan; Youli Zu
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

3.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

4.  AS1411-Induced Growth Inhibition of Glioma Cells by Up-Regulation of p53 and Down-Regulation of Bcl-2 and Akt1 via Nucleolin.

Authors:  Ye Cheng; Gang Zhao; Siwen Zhang; Fares Nigim; Guangtong Zhou; Zhiyun Yu; Yang Song; Yong Chen; Yunqian Li
Journal:  PLoS One       Date:  2016-12-01       Impact factor: 3.240

Review 5.  Agents for fluorescence-guided glioma surgery: a systematic review of preclinical and clinical results.

Authors:  Joeky T Senders; Ivo S Muskens; Rosalie Schnoor; Aditya V Karhade; David J Cote; Timothy R Smith; Marike L D Broekman
Journal:  Acta Neurochir (Wien)       Date:  2016-11-22       Impact factor: 2.216

Review 6.  Blood-brain barrier transport machineries and targeted therapy of brain diseases.

Authors:  Jaleh Barar; Mohammad A Rafi; Mohammad M Pourseif; Yadollah Omidi
Journal:  Bioimpacts       Date:  2016-12-05

7.  Analysis of Fluorescence Decay Kinetics of Indocyanine Green Monomers and Aggregates in Brain Tumor Model In Vivo.

Authors:  Dina Farrakhova; Igor Romanishkin; Yuliya Maklygina; Lina Bezdetnaya; Victor Loschenov
Journal:  Nanomaterials (Basel)       Date:  2021-11-24       Impact factor: 5.076

Review 8.  Progress in cancer drug delivery based on AS1411 oriented nanomaterials.

Authors:  Xin Tong; Lu Ga; Jun Ai; Yong Wang
Journal:  J Nanobiotechnology       Date:  2022-01-31       Impact factor: 10.435

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.